Article
A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, United States of America.
PLoS ONE (impact factor:
4.09).
01/2011;
6(3):e17377.
DOI:10.1371/journal.pone.0017377
pp.e17377
Source: PubMed
-
Article: Innate immune responses to influenza A H5N1: friend or foe?
[show abstract] [hide abstract]
ABSTRACT: Avian influenza A H5N1 remains unusual in its virulence for humans. Although infection of humans remains inefficient, many of those with H5N1 disease have a rapidly progressing viral pneumonia that leads to acute respiratory distress syndrome and death, but its pathogenesis remains an enigma. Comparison of the virology and pathogenesis of human seasonal influenza viruses (H3N2 and H1N1) and H5N1 in patients, animal models and relevant primary human cell cultures is instructive. Although the direct effects of viral replication and differences in the tropism of the virus for cells in the lower respiratory tract clearly contribute to pathogenesis, we focus here on the possible contribution of the host innate immune response in the pathogenesis of this disease.Trends in Immunology 10/2009; 30(12):574-84. · 10.40 Impact Factor -
Article: Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response.
[show abstract] [hide abstract]
ABSTRACT: Influenza A viruses of avian origin represent an emerging threat to human health as the progenitors of the next influenza pandemic. In recent years, highly pathogenic avian influenza H5N1 viruses have caused unprecedented epizootics on three continents and rare but highly fatal disease among humans exposed to diseased birds. Avian viruses of the H7 and H9 subtypes have also infected humans but generally resulted in far milder disease, yet they too should be considered as possible pandemic threats. Influenza virus infection elicits a complex network of host immune responses that, in uncomplicated influenza, results in effective control of the virus and the development of long-term memory responses. However, fatal avian H5N1 virus infection in both humans and experimental mammalian models is characterized by a high viral load in the respiratory tract, peripheral leukopenia and lymphopenia, a massive infiltration of macrophages into the lung, and dysregulation of cytokine and chemokine responses. This review focuses on avian influenza viruses as a pandemic threat, their induction of host innate immune responses in mammalian species, and the contribution of these responses to the disease process.Immunological Reviews 11/2008; 225:68-84. · 11.15 Impact Factor -
Article: Re-emergence of fatal human influenza A subtype H5N1 disease.
[show abstract] [hide abstract]
ABSTRACT: Human disease associated with influenza A subtype H5N1 re-emerged in January, 2003, for the first time since an outbreak in Hong Kong in 1997. Patients with H5N1 disease had unusually high serum concentrations of chemokines (eg, interferon induced protein-10 [IP-10] and monokine induced by interferon gamma [MIG]). Taken together with a previous report that H5N1 influenza viruses induce large amounts of proinflammatory cytokines from macrophage cultures in vitro, our findings suggest that cytokine dysfunction contributes to the pathogenesis of H5N1 disease. Development of vaccines against influenza A (H5N1) virus should be made a priority.The Lancet 03/2004; 363(9409):617-9. · 38.28 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
C3 activation byproducts
cellular infiltration
complement system
cytokine responses
dysregulation
enhanced disease
H5N1 infection
inflammatory responses
influenza infection
influenza virus subtype
innate immune
innate immunity
major component
pandemic 2009 H1N1 influenza viruses
pathogenic H5N1 influenza infections
proper viral clearance
serum proteins
severe lung damage